Birchler Brian 4
4 · IONIS PHARMACEUTICALS INC · Filed Apr 17, 2025
Insider Transaction Report
Form 4
Birchler Brian
EVP, Corp and Development Ops
Transactions
- Sale
Common Stock
2025-04-16$28.37/sh−680$19,292→ 56,660 total - Exercise/Conversion
Common Stock
2025-04-15+1,875→ 57,340 total - Exercise/Conversion
Restricted Stock Unit
2025-04-15−1,875→ 61,215 totalExercise: $0.00From: 2025-04-15→ Common Stock (1,875 underlying)
Footnotes (4)
- [F1]Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
- [F2]The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F4]Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.